Report Summarizes Chronic Inflammatory Demyelinating Polyneuropathy Study Findings from Ministry of Health of Russia (A clinical case of amiodarone- and statin-induced neuropathy with a manifestation of chronic inflammatory demyelinating...).

A report from the Ministry of Health of Russia analyzes the neurotoxic effects of amiodarone and statins on the peripheral nervous system, specifically focusing on chronic inflammatory demyelinating polyneuropathy (CIDP). The research emphasizes the importance of early identification of drug-induced neurotoxicity to minimize neurological complications and highlights the need for differential diagnosis with immune-mediated polyneuropathies. The report includes a clinical case of a 72-year-old male patient who developed demyelinating polyneuropathy after receiving amiodarone and statins, with significant improvement upon discontinuation of amiodarone. The study provides valuable insights into the frequency and manifestations of CIDP caused by these medications. [Extracted from the article]